» Articles » PMID: 27074706

The Effects of Antibiotics on the Microbiome Throughout Development and Alternative Approaches for Therapeutic Modulation

Overview
Journal Genome Med
Publisher Biomed Central
Specialty Genetics
Date 2016 Apr 15
PMID 27074706
Citations 345
Authors
Affiliations
Soon will be listed here.
Abstract

The widespread use of antibiotics in the past 80 years has saved millions of human lives, facilitated technological progress and killed incalculable numbers of microbes, both pathogenic and commensal. Human-associated microbes perform an array of important functions, and we are now just beginning to understand the ways in which antibiotics have reshaped their ecology and the functional consequences of these changes. Mounting evidence shows that antibiotics influence the function of the immune system, our ability to resist infection, and our capacity for processing food. Therefore, it is now more important than ever to revisit how we use antibiotics. This review summarizes current research on the short-term and long-term consequences of antibiotic use on the human microbiome, from early life to adulthood, and its effect on diseases such as malnutrition, obesity, diabetes, and Clostridium difficile infection. Motivated by the consequences of inappropriate antibiotic use, we explore recent progress in the development of antivirulence approaches for resisting infection while minimizing resistance to therapy. We close the article by discussing probiotics and fecal microbiota transplants, which promise to restore the microbiota after damage of the microbiome. Together, the results of studies in this field emphasize the importance of developing a mechanistic understanding of gut ecology to enable the development of new therapeutic strategies and to rationally limit the use of antibiotic compounds.

Citing Articles

Cost-effectiveness of screening, decolonisation and isolation strategies for carbapenem-resistant Enterobacterales and methicillin-resistant infections in hospitals: a sex-stratified mathematical modelling study.

Allel K, Garcia P, Peters A, Munita J, Undurraga E, Yakob L Lancet Reg Health Am. 2025; 43:101019.

PMID: 40027374 PMC: 11872075. DOI: 10.1016/j.lana.2025.101019.


Amoxicillin-induced bacterial gut dysbiosis decreases IL-1β and IL-6 expression but exacerbate lung inflammatory response against Mycobacterium bovis-Bacille Calmette-Guérin (BCG).

Miyauchi-Tavares T, Silva E, Dos Santos J, Sousa P, Braga M, Carminatti C PLoS One. 2025; 20(2):e0319382.

PMID: 40009606 PMC: 11864530. DOI: 10.1371/journal.pone.0319382.


Comprehensive analysis of vaginal microbiota in Chinese women with genital tuberculosis: implications for diagnosis and treatment.

Zhang Z, Zong X, Liu Z, Dong X, Bai H, Fan L BMC Microbiol. 2025; 25(1):52.

PMID: 39875829 PMC: 11773695. DOI: 10.1186/s12866-025-03767-1.


Impact of antibiotic prophylaxis on gut microbiota in colorectal surgery: insights from an Eastern European stewardship study.

Vacarean-Trandafir I, Amarandi R, Ivanov I, Dragos L, Mentel M, Iacob S Front Cell Infect Microbiol. 2025; 14:1468645.

PMID: 39872941 PMC: 11770057. DOI: 10.3389/fcimb.2024.1468645.


Release Profile and Antibacterial Activity of Essential Oil-Incorporated, Optimally Stabilized Type I Collagen Hydrogels.

Ersanli C, Skoufos I, Fotou K, Tzora A, Bayon Y, Mari D Bioengineering (Basel). 2025; 12(1).

PMID: 39851363 PMC: 11760836. DOI: 10.3390/bioengineering12010089.


References
1.
Lievin-Le Moal V, Servin A . Anti-infective activities of lactobacillus strains in the human intestinal microbiota: from probiotics to gastrointestinal anti-infectious biotherapeutic agents. Clin Microbiol Rev. 2014; 27(2):167-99. PMC: 3993101. DOI: 10.1128/CMR.00080-13. View

2.
Smith M, Moon H, Chowrira G, Kunst L . Heterologous expression of a fatty acid hydroxylase gene in developing seeds of Arabidopsis thaliana. Planta. 2003; 217(3):507-16. DOI: 10.1007/s00425-003-1015-6. View

3.
Chen Z, Moayeri M, Zhou Y, Leppla S, Emerson S, Sebrell A . Efficient neutralization of anthrax toxin by chimpanzee monoclonal antibodies against protective antigen. J Infect Dis. 2006; 193(5):625-33. PMC: 7110013. DOI: 10.1086/500148. View

4.
Citorik R, Mimee M, Lu T . Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases. Nat Biotechnol. 2014; 32(11):1141-5. PMC: 4237163. DOI: 10.1038/nbt.3011. View

5.
Abubucker S, Segata N, Goll J, Schubert A, Izard J, Cantarel B . Metabolic reconstruction for metagenomic data and its application to the human microbiome. PLoS Comput Biol. 2012; 8(6):e1002358. PMC: 3374609. DOI: 10.1371/journal.pcbi.1002358. View